These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 1263738

  • 1. The effect of halofenate and clofibrate on aggregation and release of serotonin by human platelets.
    Lin CY, Smith S.
    Life Sci; 1976 Mar 15; 18(6):563-8. PubMed ID: 1263738
    [No Abstract] [Full Text] [Related]

  • 2. Halofenate: a potent inhibitor of normal and hypersensitive platelets.
    Colman RW, Bennett JS, Sheridan JF, Cooper RA, Shattil SJ.
    J Lab Clin Med; 1976 Aug 15; 88(2):282-91. PubMed ID: 956686
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The action of halofenate on platelet shape change and prostaglandin synthesis.
    Favis GR, Colman RW.
    J Lab Clin Med; 1978 Jul 15; 92(1):45-52. PubMed ID: 659964
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia.
    Carvalho AC, Colman RW, Lees RS.
    Circulation; 1974 Sep 15; 50(3):570-4. PubMed ID: 4369866
    [No Abstract] [Full Text] [Related]

  • 8. Halofenate and clofibrate inhibition of pyruvate dehydrogenase from Fusarium culmorum.
    Madhosingh C, Orr W.
    J Environ Sci Health B; 1985 Apr 15; 20(2):201-14. PubMed ID: 3998411
    [Abstract] [Full Text] [Related]

  • 9. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction].
    Cattaneo M, D'Angelo A, Mannucci PM, Pareti F, Vanasia S, Viganò.
    Clin Ter; 1980 Feb 29; 92(4):359-68. PubMed ID: 6108818
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacology of platelet-suppressive agents.
    Wautier JL, Caen JP.
    Semin Thromb Hemost; 1979 Feb 29; 5(4):293-315. PubMed ID: 386519
    [No Abstract] [Full Text] [Related]

  • 11. Clinical pharmacology of platelets.
    Packham MA, Mustard JF.
    Blood; 1977 Oct 29; 50(4):555-73. PubMed ID: 332253
    [No Abstract] [Full Text] [Related]

  • 12. The role of platelets in the genesis of ischemia.
    Colman RW.
    Ann N Y Acad Sci; 1982 Oct 29; 382():190-203. PubMed ID: 6282171
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Platelet function in hyperbetalipoproteinemia.
    Colman RW.
    Thromb Haemost; 1978 Apr 30; 39(2):284-93. PubMed ID: 580982
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients.
    Lisch HJ, Patsch J, Sailer S, Braunsteiner H.
    Atherosclerosis; 1975 Apr 30; 21(3):391-9. PubMed ID: 1148032
    [Abstract] [Full Text] [Related]

  • 16. Effects of halothane on platelet function.
    Dalsgaard-Nielsen J, Gormsen J.
    Thromb Haemost; 1980 Dec 19; 44(3):143-5. PubMed ID: 7466741
    [Abstract] [Full Text] [Related]

  • 17. Investigation of the role of arachidonic acid in platelet function and mechanisms for suppression of prostaglandin biosynthesis.
    Huzoor-Akbar, Ardlie NG.
    Br J Haematol; 1978 May 19; 39(1):71-81. PubMed ID: 666979
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The metabolic spectrum of halofenate.
    Ryan JR.
    Int J Clin Pharmacol Biopharm; 1975 Jul 19; 12(1-2):239-43. PubMed ID: 51838
    [Abstract] [Full Text] [Related]

  • 20. Effect of halofenate and clofibrate on lipid synthesis in rat adipocytes.
    Greenspan MD, Germershausen JI, Mackow R.
    Biochim Biophys Acta; 1975 Feb 20; 380(2):190-8. PubMed ID: 1120140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.